“…Exocrine pancreatic insufficiency (EPI) is supplemented in all patients operated for TP, where it is considered that all suffer from EPI, whereas in the meta-analysis of the Dutch pancreatic cancer group ( 1 ) of 495 patients operated on for EPI, only 43.5% suffered from EPI and were substituted. The quality of life score according to the EORTC QLQ-C30 questionnaire was 64% (58–69%) in the Dutch group meta-analysis and 79% (64–95%) in the Verona group study ( 2 - 7 ).…”